Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus AASLD/IDSA HCV Guidance Panel, RT Chung, GL Davis, DM Jensen, ... Hepatology 62 (3), 932-954, 2015 | 845 | 2015 |
Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure JR Castillo-Mancilla, JH Zheng, JE Rower, A Meditz, EM Gardner, ... AIDS research and human retroviruses 29 (2), 384-390, 2013 | 340 | 2013 |
Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection AIHCVG Panel Clinical infectious diseases: an official publication of the Infectious …, 2018 | 334 | 2018 |
An HIV preexposure prophylaxis demonstration project and safety study for young MSM SG Hosek, B Rudy, R Landovitz, B Kapogiannis, G Siberry, B Rutledge, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 74 (1), 21-29, 2017 | 318 | 2017 |
Intracellular tenofovir-diphosphate and emtricitabine-triphosphate in dried blood spots following directly observed therapy PL Anderson, AY Liu, JR Castillo-Mancilla, EM Gardner, SM Seifert, ... Antimicrobial agents and chemotherapy 62 (1), 10.1128/aac. 01710-17, 2018 | 262 | 2018 |
The effect of lopinavir/ritonavir on the renal clearance of tenofovir in HIV‐infected patients JJ Kiser, ML Carten, CL Aquilante, PL Anderson, P Wolfe, TM King, ... Clinical Pharmacology & Therapeutics 83 (2), 265-272, 2008 | 252 | 2008 |
Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection PL Anderson, JJ Kiser, EM Gardner, JE Rower, A Meditz, RM Grant Journal of antimicrobial chemotherapy 66 (2), 240-250, 2011 | 242 | 2011 |
Safety and feasibility of antiretroviral preexposure prophylaxis for adolescent men who have sex with men aged 15 to 17 years in the United States SG Hosek, RJ Landovitz, B Kapogiannis, GK Siberry, B Rudy, B Rutledge, ... JAMA pediatrics 171 (11), 1063-1071, 2017 | 238 | 2017 |
Clinical and genetic determinants of intracellular tenofovir diphosphate concentrations in HIV-infected patients JJ Kiser, CL Aquilante, PL Anderson, TM King, ML Carten, CV Fletcher JAIDS Journal of Acquired Immune Deficiency Syndromes 47 (3), 298-303, 2008 | 204 | 2008 |
Drug/drug interaction between lopinavir/ritonavir and rosuvastatin in healthy volunteers JJ Kiser, JG Gerber, JA Predhomme, P Wolfe, DM Flynn, DW Hoody JAIDS Journal of Acquired Immune Deficiency Syndromes 47 (5), 570-578, 2008 | 189 | 2008 |
Review and management of drug interactions with boceprevir and telaprevir JJ Kiser, JR Burton, PL Anderson, GT Everson Hepatology 55 (5), 1620-1628, 2012 | 182 | 2012 |
Drug–drug interactions during antiviral therapy for chronic hepatitis C JJ Kiser, JR Burton Jr, GT Everson Nature reviews Gastroenterology & hepatology 10 (10), 596-606, 2013 | 173 | 2013 |
Direct-acting antiviral agents for hepatitis C virus infection JJ Kiser, C Flexner Annual review of pharmacology and toxicology 53 (1), 427-449, 2013 | 128 | 2013 |
Application of an intracellular assay for determination of tenofovir-diphosphate and emtricitabine-triphosphate from erythrocytes using dried blood spots JH Zheng, C Rower, K McAllister, J Castillo-Mancilla, B Klein, A Meditz, ... Journal of pharmaceutical and biomedical analysis 122, 16-20, 2016 | 126 | 2016 |
Determination of nucleoside analog mono-, di-, and tri-phosphates in cellular matrix by solid phase extraction and ultra-sensitive LC–MS/MS detection LR Bushman, JJ Kiser, JE Rower, B Klein, JH Zheng, ML Ray, ... Journal of pharmaceutical and biomedical analysis 56 (2), 390-401, 2011 | 122 | 2011 |
Liquid chromatography–tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cells T King, L Bushman, J Kiser, PL Anderson, M Ray, T Delahunty, ... Journal of chromatography B 843 (2), 147-156, 2006 | 110 | 2006 |
Plasma and intracellular population pharmacokinetic analysis of tenofovir in HIV-1-infected patients G Baheti, JJ Kiser, PL Havens, CV Fletcher Antimicrobial agents and chemotherapy 55 (11), 5294-5299, 2011 | 94 | 2011 |
Assessing the effectiveness of pharmacy-based adherence interventions on antiretroviral adherence in persons with HIV KC Henderson, J Hindman, SC Johnson, RJ Valuck, JJ Kiser AIDS patient care and STDs 25 (4), 221-228, 2011 | 88 | 2011 |
Intracellular tenofovir and emtricitabine anabolites in genital, rectal, and blood compartments from first dose to steady state SM Seifert, X Chen, AL Meditz, JR Castillo-Mancilla, EM Gardner, ... AIDS research and human retroviruses 32 (10-11), 981-991, 2016 | 82 | 2016 |
Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir … PL Havens, JJ Kiser, CB Stephensen, R Hazra, PM Flynn, CM Wilson, ... Antimicrobial agents and chemotherapy 57 (11), 5619-5628, 2013 | 82 | 2013 |